Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Select Medical Holdings Company Profile (NYSE:SEM)

Consensus Ratings for Select Medical Holdings (NYSE:SEM) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s)
Consensus Rating:Hold (Score: 1.67)
Consensus Price Target: $13.67 (17.67% downside)

Analysts' Ratings History for Select Medical Holdings (NYSE:SEM)
Show:
DateFirmActionRatingPrice TargetActions
5/13/2015Deutsche BankReiterated RatingHold$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Deutsche BankInitiated CoverageHold$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2015JMP SecuritiesDowngradeMarket Perform -> Underperform$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Robert W. BairdDowngradeOutperform -> Neutral$16.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2014Robert W. BairdBoost Price Target$15.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2014SusquehannaBoost Price Target$15.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2014RBC CapitalUpgradeSector Perform -> Outperform$9.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2014Wells Fargo & Co.UpgradeUnderperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2014Robert W. BairdUpgradeNeutral -> Outperform$10.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2014SusquehannaUpgradeNeutral -> Positive$9.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/23/2013Standpoint ResearchDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2013Wells Fargo & Co.DowngradeMarket Perform -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2013SidotiInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2013Standpoint ResearchInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2013 forward)